Loading clinical trials...
Loading clinical trials...
Colorectal Cancer Post-surgical Therapeutic Effect Assessment and Recurrence Monitoring by Methylated SEPT9
Conditions
Interventions
plasma mSEPT9 level
Locations
4
China
The Chinese PLA 302th hospital
Beijing, China
The Chinese PLA 309th hospital
Beijing, China
The Chinese PLA general hospital
Beijing, China
The first affiliated hospital of the Chinese PLA general hospital
Beijing, China
Start Date
January 1, 2016
Primary Completion Date
December 31, 2017
Completion Date
December 31, 2017
Last Updated
November 7, 2017
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
BioChain (Beijing) Science and Technology, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions